EP 0628056 A1 19941214 - DIRECTED HUMAN IMMUNE GLOBULIN FOR THE PREVENTION AND TREATMENT OF STAPHYLOCOCCAL INFECTIONS.
Title (en)
DIRECTED HUMAN IMMUNE GLOBULIN FOR THE PREVENTION AND TREATMENT OF STAPHYLOCOCCAL INFECTIONS.
Title (de)
ZIELGERICHTETE HUMANE IMMUNGLOBULINE ZUR VERHINDERUNG UND BEHANDLUNG VON STAPHYLOCOCCEN-INFEKTIONEN.
Title (fr)
IMMUNOGLOBULINE HUMAINE DIRIGEE POUR LA PREVENTION ET LE TRAITEMENT DE STAPHYLOCOCCIES.
Publication
Application
Priority
- US 9209830 W 19921109
- US 80431792 A 19920225
Abstract (en)
[origin: WO9317044A1] This invention is directed to a Directed Human Immunoglobulin and compositions thereof for preventing or treating staphylococcal infections such as S. epidermidis.
Abstract (fr)
L'invention se rapporte à l'immunoglobuline humaine dirigée et à des compositions contenant ladite globuline pour la prévention et le traitement de staphylococcies telle que la Staphilococeis epidermidis.
IPC 1-7
C07K 15/06; A61K 35/16; A61K 39/40; A61K 39/085; A61K 39/395; A61K 49/00; C12Q 1/00; G01N 33/536
IPC 8 full level
G01N 33/569 (2006.01); A61K 35/16 (2006.01); A61K 39/395 (2006.01); A61P 31/04 (2006.01); A61P 37/04 (2006.01); C07K 16/12 (2006.01); C12Q 1/18 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP)
A61P 31/04 (2018.01); A61P 37/04 (2018.01); C07K 16/1271 (2013.01); C12Q 1/18 (2013.01); A61K 38/00 (2013.01); A61K 39/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/77 (2013.01); G01N 2333/31 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE
DOCDB simple family (publication)
WO 9317044 A1 19930902; AU 3271893 A 19930913; AU 673508 B2 19961114; CA 2117480 A1 19930902; EP 0628056 A1 19941214; EP 0628056 A4 19970305; JP H08504167 A 19960507
DOCDB simple family (application)
US 9209830 W 19921109; AU 3271893 A 19921109; CA 2117480 A 19921109; EP 93901435 A 19921109; JP 51480092 A 19921109